Brigham and Women's Hospital

Not yet accepting

NK Cell Therapy Post-Transplant

Cytokine-induced Memory-like Natural Killer Cell Therapy After Hematopoietic Stem Cell Transplantation for Eradication of Measurable Residual Disease, a Phase I/Ib Clinical Trial
Learn more
  • Natural Killer Cells (Allogeneic)
  • Phase 1

Not yet accepting

MBG453

TIM3 Inhibition With MBG453 for Patients With Lower Risk MDS: an Adaptive Two-Stage Phase II Clinical Trial
Learn more
  • Monoclonal Antibody
  • TIM-3
  • Phase 2

Not yet accepting

HEME Hospice - Home Transfusion Program

Supportive Transfusion Program for Patients With Hematologic Malignancies: A Cluster Randomized Trial
Learn more
  • Randomization